Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-100
Closed -$8K 10664
2014
Q2
$8K Buy
+100
New +$6.77K ﹤0.01% 9108
2014
Q1
Sell
-1,000
Closed -$71K 10703
2013
Q4
$71K Sell
1,000
-1,700
-63% -$132K ﹤0.01% 6491
2013
Q3
$206K Sell
2,700
-400
-13% -$27.7K ﹤0.01% 5139
2013
Q2
$201K Buy
+3,100
New +$167K ﹤0.01% 5091

Other funds holding PRLB

UBS's PRLB Position: Q3 2014 in Review

UBS reduced its Protolabs (PRLB) stake by 39% in Q3 2014, selling an estimated $2M and leaving 40,167 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

UBS first reported a position in PRLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.2M in Q4 2013. 186 funds tracked by Wall St. Rank hold PRLB as of Q3 2014.

  • UBS held 40,167 shares of Protolabs worth $2.77M as of Q3 2014.
  • UBS sold 25,514 Protolabs shares in Q3 2014, an estimated $2M.
  • Protolabs made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2600 holding.
  • UBS first reported a position in Protolabs in Q2 2013 and has held it in 6 quarters since.
  • UBS's Protolabs position peaked at $9.2M in Q4 2013.
  • 186 funds tracked by Wall St. Rank held Protolabs as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.